Fred Hutch, NIH experts outlined plan for COVID-19 vaccines
On May 11, 2020, in a perspective published by the journal Science, Dr. Larry Corey from the Fred…
-
-
Biotechnology | COVID-19 | Diagnostics | FDA
The FDA issued EUA for first antigen test to help in rapid detection of virus that causes COVID-19 in patients
On May 9, 2020, the U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA)…
-
Biotechnology | COVID-19 | Diagnostics | Environmental | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Rice University COVID-19 research fund backed six new initiatives
On May 8, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had funded…
-
Research from University of Washington demonstrated high performance of Abbott’s SARS-CoV-2 antibody blood test
On May 8, 2020, Abbott announced new research, published in the Journal of Clinical Microbiology, which found that…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Pharmaceutical | Therapeutics | Vaccine
USPTO announced COVID-19 Prioritized Examination Pilot Program for small and micro entities
On May 8, 2020, the U.S. Patent and Trademark Office (USPTO) announced a new COVID-19 Prioritized Examination Pilot…
-
NIH clinical trial testing antiviral remdesivir plus antiiInflammatory drug baricitinib for COVID-19 began
On May 8, 2020, the U.S. National Institutes of Health (NIH) announced that a randomized, controlled clinical trial…
-
The FDA issued EUA for first diagnostic test using at-home collection of saliva specimens
On May 8, 2020, the U.S. Food and Drug Administration (FDA) announced it had issued the first emergency…
-
RedHill Biopharma received FDA approval for COVID-19 clinical study with opaganib in the U.S.
On May 8, 2020, RedHill Biopharma announced the U.S. Food and Drug Administration (FDA) had approved its Investigational…
-
The CoVIg-19 Plasma Alliance was established
On May 8, 2020, the CoVIg-19 Plasma Alliance was announced, an unprecedented partnership of the world’s leading plasma…
-
Bharat Biotech leads a CSIR-NMITLI supported project to develop human antibodies or COVID-19 therapy
On May 8, 2020, the Council of Scientific and Industrial Research (CSIR) under its flagship programme NMITLI announced…
-
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease
Quidel’s received Emergency Authorization for Rapid Antigen COVID-19 diagnostic assay
On May 8, 2020, Quidel announced it had received Emergency Use Authorization (EUA) from the FDA to market…
-
AbbVie completed acquisition of Allergan for nearly $62 billion
On May 8, 2020, AbbVie announced it had completed its acquisition of Allergan following receipt of regulatory approval…
-
OPKO Health’s BioReference Laboratories launched COVID-19 antibody screening for New York City residents
On May 8, 2020, BioReference Laboratories, an OPKO Health company, announced the launch of COVID-19 antibody screening available…
-
Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine
On May 7, 2020, Entos Pharmaceuticals announced a partnership with Precision NanoSystems, Inc., (PNI), a global leader in…
-
Air Force Genetics Laboratory, DHA collaborate to further sequence SARS-CoV-2 code
On May 11, 2020, the Air Force Genetics Center of Excellence at Keesler Air Force Base in Biloxi,…
-
COVID-19 in-home monitoring program launched
On May 7, 2020, Washington University in St. Louis announced that people with COVID-19 who are seen by…
-
Royal DSM accelerated Dutch Covid-19 testing by making 28 million nose swabs
On May 7, 2020, Royal DSM announced it had started manufacturing nose swabs for the first time to…
-
NIH-supported research examines impact of COVID-19 on rare diseases community
On May 7, 2020, the National Institutes of Health (NIH) announced a new online survey launched by the…
-
Risk factors for COVID-19 death revealed in world’s largest analysis of patient records to date
On May 7, 2020, academics at the University of Oxford and the London School of Hygiene & Tropical…
-
Sanger scientist received Chan Zuckerberg Initiative support for COVID-19 study
On May 7, 2020, the Wellcome Sanger Institute announced that Roser Vento-Tormo, a Group Leader was one of…
-
Gilead announces approval of Veklury (remdesivir) in Japan for patients with severe COVID-19
On May 7, 2020, Gilead announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Medical Device | Non-Profit Research
OPTI Medical Systems received FDA Emergency Use Authorization for OPTI SARS-CoV-2 RNA PCR test kit for detection of Virus causing COVID-19
On May 7, 2020, OPTI Medical Systems, an IDEXX Laboratories subsidiary announced the U.S. Food and Drug Administration…
-
Tonix Pharma announced research collaboration and exclusive agreement with the University of Alberta to develop novel c-based vaccines for prevention of COVID-19
On May 7, 2020, Tonix Pharmaceuticals and the University of Alberta announced a research collaboration and exclusive licensing…
-
First large study of hydroxychloroquine does not support routine use in COVID-19 patients
On May 7, 2020, a study of nearly 1,400 patients with moderate to severe COVID-19 disease at a…
-
CoVIg-19 Plasma Alliance builds strong momentum through expanded membership and clinical trial collaboration
On May 7, 2020, the CoVId-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the…
-
Laurent Pharmaceuticals received Health Canada’s approval to initiate COVID-19 clinical trial
On May 6, 2020, Laurent Pharmaceuticals announced that it has obtained the approval from Health Canada to initiate…
-
PharmaCyte Biotech received medical devices registration and submited pre-EUA application to the FDA for COVID-19 diagnostic kit
On May 6, 2020, PharmaCyte Biotech announced it had received Medical Devices Establishment Registration with the U.S. Food and…
-
3M and Ford begin shipping newly designed powered air-purifying respirators for health care workers fighting COVID-19
On May 6, 2020, 3M and Ford announced that newly designed powered air-purifying respirators (PAPRs), developed are on…
-
Meridian Bioscience partnered with QuantuMDx on COVID-19 assay
On May 6, 2020, Meridian Bioscience announced a collaboration with QuantuMDx on its newly launched SARS-CoV-2 assay for…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
FDA approved first targeted therapy to treat aggressive form of lung cancer
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
